These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2366059)

  • 1. Electroconvulsive therapy emergence agitation and succinylcholine dose.
    Swartz CM
    J Nerv Ment Dis; 1990 Jul; 178(7):455-7. PubMed ID: 2366059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECT emergence agitation and methohexital-succinylcholine interaction. Case report.
    Swartz CM
    Gen Hosp Psychiatry; 1993 Sep; 15(5):339-41. PubMed ID: 8307349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-ECT agitation and plasma lactate concentrations.
    Auriacombe M; Rénéric JP; Usandizaga D; Gomez F; Combourieu I; Tignol J
    J ECT; 2000 Sep; 16(3):263-7. PubMed ID: 11005048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement.
    Devanand DP; Sackeim HA
    Gen Hosp Psychiatry; 1992 Sep; 14(5):345-9. PubMed ID: 1521790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial.
    Mirzakhani H; Guchelaar HJ; Welch CA; Cusin C; Doran ME; MacDonald TO; Bittner EA; Eikermann M; Nozari A
    Anesth Analg; 2016 Sep; 123(3):587-96. PubMed ID: 26967896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation.
    Hermida AP; Janjua AU; Tang Y; Syre SR; Job G; McDonald WM
    J Psychiatr Pract; 2016 Nov; 22(6):459-462. PubMed ID: 27824778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting amnesia, seizure duration, and efficacy in ECT.
    Miller AL; Faber RA; Hatch JP; Alexander HE
    Am J Psychiatry; 1985 Jun; 142(6):692-6. PubMed ID: 4003587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroconvulsive therapy in the medically ill patient.
    Bidder TG
    Psychiatr Clin North Am; 1981 Aug; 4(2):391-405. PubMed ID: 7024939
    [No Abstract]   [Full Text] [Related]  

  • 10. An intrasubject comparison of two doses of succinylcholine in modified electroconvulsive therapy.
    Murali N; Saravanan ES; Ramesh VJ; Gangadhar BN; Jananakiramiah N; Kumar SS; Christopher R; Subbakrishna DK
    Anesth Analg; 1999 Nov; 89(5):1301-4. PubMed ID: 10553856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time dependent therapeutic effects of single electroconvulsive therapy (ECT) in endogenous depression.
    Jagadeesh HN; Gangadhar BN; Janakiramaiah N; Subbakrishna DK; Jain S
    J Affect Disord; 1992 Apr; 24(4):291-5. PubMed ID: 1578085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme variability in succinylcholine dose for muscle relaxation in electroconvulsive therapy.
    Bryson EO; Kellner CH; Li EH; Aloysi AS; Majeske M
    Australas Psychiatry; 2018 Aug; 26(4):391-393. PubMed ID: 29504412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General Anaesthesia Protocols for Patients Undergoing Electroconvulsive Therapy: Retrospective analysis of 504 sessions over a five-year period at a tertiary care hospital in Oman.
    Narayanan A; Lal C; Al-Sinawi H
    Sultan Qaboos Univ Med J; 2017 Feb; 17(1):e43-e49. PubMed ID: 28417028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Succinylcholine shortage and electroconvulsive therapy.
    Maixner DF; Hermida AP; Husain MM; Rudowski MR; Reti IM
    Am J Psychiatry; 2011 Sep; 168(9):986-7. PubMed ID: 21890805
    [No Abstract]   [Full Text] [Related]  

  • 15. A naturalistic comparison of two right unilateral electroconvulsive therapy dosing protocols: 2-3X seizure threshold versus fixed high-dose.
    Ward WK; Lush P; Kelly M; Frost AD
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):429-33. PubMed ID: 16884443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postictal excitement following bilateral and right-unilateral ECT.
    Sackeim HA; Decina P; Malitz S; Hopkins N; Yudofsky SC; Prohovnik I
    Am J Psychiatry; 1983 Oct; 140(10):1367-8. PubMed ID: 6624976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychomotor retardation and agitation in depression. Relationship to age, sex, and response to treatment.
    Avery D; Silverman J
    J Affect Disord; 1984 Aug; 7(1):67-76. PubMed ID: 6236245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.
    Augoustides JG; Greenblatt E; Abbas MA; O'Reardon JP; Datto CJ
    J ECT; 2002 Dec; 18(4):213-7. PubMed ID: 12468998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy.
    Cheam EW; Critchley LA; Chui PT; Yap JC; Ha VW
    Can J Anaesth; 1999 Jan; 46(1):49-51. PubMed ID: 10078403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methohexital and succinylcholine dosing for electroconvulsive therapy (ECT): actual versus ideal.
    Bryson EO; Aloysi AS; Popeo DM; Bodian CA; Pasculli RM; Briggs MC; Kellner CH
    J ECT; 2012 Sep; 28(3):e29-30. PubMed ID: 22914634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.